
Dr Emil KendziorraFounder & CEO
In this interview, Emil Kendziora discusses the future of cryopreservation, longevity science, and the pursuit of life extension. He explains why he views cryostasis as a potential option for individuals facing terminal illness and how advances in medicine could expand future possibilities. Kendziora also shares his journey from practicing medicine to entrepreneurship and outlines his mission to make cryopreservation more accessible, affordable, and scientifically rigorous.
Founder Stats
- Health & Wellness
- Started 2020
- $50K-$250K/mo
- 11–50 team
- Berlin, Germany
About Dr Emil Kendziorra
Emil Kendziora is the founder and CEO of Tomorrow.Bio, a cryopreservation company focused on advancing cryostasis and longevity science in Europe. Trained as a medical doctor, he transitioned into entrepreneurship to explore technologies that could extend healthy lifespans and preserve future medical opportunities. Through Tomorrow.Bio, Kendziora works to increase awareness, accessibility, and scientific development within the emerging field of human cryopreservation.
Interview
June 12, 2026
What first inspired your interest in longevity and life extension?
Why did you move from medicine and research into entrepreneurship?
How did your previous startups prepare you for Tomorrow.Bio?
Why do you describe Tomorrow.Bio as your life's work?
What makes cryopreservation different from other longevity approaches?
How do you explain cryopreservation to someone hearing about it for the first time?
What are the biggest misconceptions about cryopreservation?

Many people think it belongs entirely in science fiction. In reality, preservation is already possible today. The challenge is future revival. We are very transparent about that. Nobody can currently bring a cryopreserved person back, but the goal is to create that possibility through future scientific progress.
How do you think about risk when discussing cryopreservation?

I never describe it as a guarantee. Cryopreservation is about improving your odds. If someone chooses burial or cremation, the chance of returning is effectively zero. Cryopreservation offers at least a possibility, and our job is to keep improving those odds through research, governance, and long-term planning.
What leadership lesson has helped you most as a founder?
Why do you focus more on mission than short-term profits?
How do you measure success for Tomorrow.Bio?
Why is affordability such an important goal?
Table Of Questions
Video Interviews with Dr Emil Kendziorra
The Startup Freezing Humans For Tomorrow - Interview with Dr Emil Kendziorra, CEO of Tomorrow.bio
Cite This Interview
Use this interview in your research, article, or academic work
Related Interviews

Cobi Blumenfeld-Gantz
Co-Founder & CEO at Chapter
In this interview, Chapter co-founder and CEO Cobi Blumenfeld-Gantz discusses the company's rise to a $3 billion valuation in the senior health navigation market. He…

Mark Bertolin
CEO at Oscar Health
In this interview, Oscar Health CEO Mark Bertolini explains how technology, AI, and consumer choice can reshape the health insurance industry. He discusses the future…

Cathie Wood
Founder, CEO & CIO at ARK Invest
In this interview, ARK Invest founder and CEO Cathie Wood discusses Bitcoin bottoming and emerging into a broad multi-year uptrend. Wood details critical macroeconomic metrics,…

Collin Kettell
Founder & CEO at Palisades Goldcorp
In this interview, Palisades Goldcorp founder and CEO Collin Kettell discusses their unique warrant-centric resource investment strategy at the Rick Rule Symposium. He details the…

Rajan Sethuraman
CEO at LatentView Analytics
In this interview, LatentView Analytics CEO Rajan Sethuraman discusses the firm's non-exclusive services partnership with Anthropic to deploy Claude in enterprise environments. He details LatentView's…

Krishna Rangasayee
Founder & CEO at SiMa.ai
In this interview, SiMa.ai founder and CEO Krishna Rangasayee discusses the transition of physical AI from early adoption to mainstream production. Speaking at the RAISE…